Marija Stanković

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

A novel role for cardiac ankyrin repeat protein Ankrd1/CARP as a co-activator of the p53 tumor suppressor protein

Snežana Kojić, Aleksandra Nestorovic, Ljiljana Rakićević et al. · Archives of Biochemistry and Biophysics · 2010 · 93 citations

Signal Transduction, Medicine, Pathology +6

Therapeutic Potential of Nitric Oxide-Modified Drugs in Colon Cancer Cells

Marija Mojić, Sanja Mijatović, Danijela Maksimović‐Ivanić et al. · Molecular Pharmacology · 2012 · 29 citations

TNF-α-308 promotor polymorphism in patients with chronic obstructive pulmonary disease and lung cancer

Marija Stanković, Aleksandra Nestorovic, Andrija Tomović et al. · Neoplasma · 2009 · 28 citations

Asthma, Advanced Lung Disease, Lung Inflammation +17